Clinical Research Directory
Browse clinical research sites, groups, and studies.
Omnipod 5 Implementation in Belgian Paediatric Diabetes Care
Sponsor: Queen Fabiola Children's University Hospital
Summary
This study will evaluate the introduction and use of the Omnipod® 5 hybrid closed-loop insulin delivery system in children and adolescents with type 1 diabetes following its reimbursement in Belgium. The study will describe how quickly the system is adopted in routine paediatric diabetes care, which patients are offered this technology, and the reasons for choosing Omnipod® 5. It will also evaluate changes in the use of different insulin pump systems and assess diabetes control, safety, and continued use of Omnipod® 5 during follow-up. The study is observational, meaning that participants will receive their usual diabetes care and their treatment will not be changed for research purposes. Information collected during routine diabetes follow-up, including glucose sensor, insulin pump, and medical record data, will be analysed. No additional examinations, blood tests, or hospital visits will be required for participation.
Official title: One-year Implementation of the Omnipod® 5 Hybrid Closed-loop System Following Reimbursement in Belgium: Real-world Experience From a Paediatric Diabetes Centre
Key Details
Gender
All
Age Range
1 Year - 16 Years
Study Type
OBSERVATIONAL
Enrollment
200
Start Date
2026-09-01
Completion Date
2027-12-31
Last Updated
2026-08-25
Healthy Volunteers
No
Conditions
Interventions
Tubeless Hybrid Closed-Loop Insulin Delivery System
A tubeless hybrid closed-loop insulin delivery system that combines a wearable insulin pump (Pod) with continuous glucose monitoring to automatically adjust insulin delivery. The system is used as part of routine clinical care in children and adolescents with type 1 diabetes.